Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fallon

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2017
Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profilesPu Shi, Mingxiang Liao, Bei-Ching Chuang, et al.
Advanced Nanobiomed Research|December 20, 2021
Extracellular Vesicles as Drug Delivery System for Treatment of Neurodegenerative Disorders: Optimization of the Cell SourceMatthew J Haney, Yuling Zhao, John K Fallon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 27, 2025
Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypesBethany D Latham, Pegah Montazeri, Raeanne M Lanphier, et al.
The AAPS Journal|September 19, 2022
Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist)Philip Sandoval, Bei-Ching Chuang, John K Fallon, et al.
Frontiers in Pharmacology|December 12, 2025
Estrogen associations with human pregnancy related increases in cytochrome P450 3A activityMuluneh M Fashe, Jonghwa Lee, Joseph T Grieco, et al.
JAMA|June 24, 2000
Informed decisions for extremely low-birth-weight infantsG Culver, K Fallon, R B Londner, et al.
Psychological Trauma : Theory, Research, Practice and Policy|February 9, 2016
Group-delivered cognitive/exposure therapy for PTSD in women veterans: A randomized controlled trialDiane T Castillo, Christine L Chee, Erica Nason, et al.
Clinical and Translational Science|February 14, 2022
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumorsOlumide B Gbolahan, Bert H O'Neil, Autumn J McRee, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR<sup>-</sup>) RatsJacqueline Bezençon, Chitra Saran, Janine Hussner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 20, 2021
Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding ProteinsLiberta Cuko, Zofia Duniec-Dmuchowski, Elizabeth A Rondini, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2017
Efflux transporter breast cancer resistance protein dominantly expresses on the membrane of red blood cells, hinders partitioning of its substrates into the cells, and alters drug-drug interaction profilesPu Shi, Mingxiang Liao, Bei-Ching Chuang, et al.
Advanced Nanobiomed Research|December 20, 2021
Extracellular Vesicles as Drug Delivery System for Treatment of Neurodegenerative Disorders: Optimization of the Cell SourceMatthew J Haney, Yuling Zhao, John K Fallon, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 27, 2025
Interindividual variability in imatinib metabolism in human liver microsomes and primary human hepatocytes: Impact of CYP2C8 and CYP3A phenotypesBethany D Latham, Pegah Montazeri, Raeanne M Lanphier, et al.
The AAPS Journal|September 19, 2022
Sinusoidal Organic Anion-Transporting Polypeptide 1B1/1B3 and Bile Canalicular Multidrug Resistance-Associated Protein 2 Play an Essential Role in the Hepatobiliary Disposition of a Synthetic Cyclic Dinucleotide (STING Agonist)Philip Sandoval, Bei-Ching Chuang, John K Fallon, et al.
Frontiers in Pharmacology|December 12, 2025
Estrogen associations with human pregnancy related increases in cytochrome P450 3A activityMuluneh M Fashe, Jonghwa Lee, Joseph T Grieco, et al.
JAMA|June 24, 2000
Informed decisions for extremely low-birth-weight infantsG Culver, K Fallon, R B Londner, et al.
Psychological Trauma : Theory, Research, Practice and Policy|February 9, 2016
Group-delivered cognitive/exposure therapy for PTSD in women veterans: A randomized controlled trialDiane T Castillo, Christine L Chee, Erica Nason, et al.
Clinical and Translational Science|February 14, 2022
A phase I evaluation of the effect of curcumin on dose-limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumorsOlumide B Gbolahan, Bert H O'Neil, Autumn J McRee, et al.
Journal of Pharmaceutical Sciences|October 15, 2020
Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR<sup>-</sup>) RatsJacqueline Bezençon, Chitra Saran, Janine Hussner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 20, 2021
Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding ProteinsLiberta Cuko, Zofia Duniec-Dmuchowski, Elizabeth A Rondini, et al.
Pageof 12